Rachel Occhiogrosso Abelman, MD (@RachelAbelman) profile picture

Rachel Occhiogrosso Abelman, MD

@RachelAbelman

Breast Medical Oncologist at @MGHCancerCenter by way of @DanaFarber @BrighamMedRes. Interested in antibody-drug conjugates. Views my own.

 Boston, MA
Joined December 2022
  • Tweets13
  • Following74
  • Followers156
3Media
Photo by Rachel Occhiogrosso Abelman, MD (@RachelAbelman)Photo by Rachel Occhiogrosso Abelman, MD (@RachelAbelman)Photo by Rachel Occhiogrosso Abelman, MD (@RachelAbelman)
Belated post -- so grateful for the opportunity to attend #ASCO2024 and for such amazing mentorship and support! Looking forward to what comes next. @MGHBreastOnc @dradityabardia @BeverlyMoy @ConquerCancerFd
Image from Rachel Occhiogrosso Abelman, MD (@RachelAbelman)
Image from Rachel Occhiogrosso Abelman, MD (@RachelAbelman)
1
1
12
1,656
So excited to for the opportunity to join @ASCOTECAG this upcoming year! Can't wait to get started.
Image from Rachel Occhiogrosso Abelman, MD (@RachelAbelman)
1
2
8
1,739
Such a fantastic experience presenting @AACR on this exciting collaboration! @MGHCancerCenter
Aditya Bardia, MD (@dradityabardia) profile pictureAditya Bardia, MD@dradityabardia8 Apr 2024
Excellent presentation at @AACR by @RachelAbelman on TOP1 mutations mediating cross-resistance to ADCs. Implications for ADC sequencing and drug development in MBC. #bcsm
Image from Aditya Bardia, MD (@dradityabardia)
Image from Aditya Bardia, MD (@dradityabardia)
2
11
930
Thank you for the great opportunity to talk about ADCs in HER2+ breast cancer!
Yael Bar (@BarYaelMD) profile pictureYael Bar@BarYaelMD22 Jul 2023
Replying to @RachelAbelman
@RachelAbelman from @MGHBreastOnc is giving an excellent talk about Antibody Drug Conjugates for HER2 positive breast cancer at the #HarvardBreastCancerCourse
Image from Yael Bar (@BarYaelMD)
1
656
Such an amazing experience presenting our work on ADC sequencing as a Poster Discussion at #ASCO23! Thank you for the fantastic mentorship and opportunity @dradityabardia @MGHBreastOnc.
Image from Rachel Occhiogrosso Abelman, MD (@RachelAbelman)
3
4
1
25
2,734
Can't wait to share our work and learn from these abstracts! Looking forward to #ASCO23 this weekend.
Paolo Tarantino (@PTarantinoMD) profile picturePaolo Tarantino
@PTarantinoMD29 May 2023
With #ASCO23-week officially here, it is time for a #top10 list of breast abstracts! Several potentially practice-changing trials to be presented during the congress. Take a look, share if you found it useful and feel free to recommend additional impactful abstracts to add! #bcsm
Image from Paolo Tarantino (@PTarantinoMD)
2
560
So excited to share our most recent work! @MGHBreastOnc @dradityabardia
Wu, Bogang (@bogang_wu) profile pictureWu, Bogang@bogang_wu17 Feb 2023
New review article by our team from @MGHBreastOnc @MGHCancerCenter discussed most recent knowledge and provided insights in antibody drug conjugate resistance. mdpi.com/2072-6694/15/4/1278
Mechanisms of Resistance to Antibody–Drug Conjugates

Mechanisms of Resistance to Antibody–Drug Conjugates

Antibody–drug conjugates (ADCs), with antibodies targeted against specific antigens linked to cytotoxic payloads, offer the opportunity for a more specific delivery of chemotherapy and other bioact...

mdpi.com
6
581
Rachel Occhiogrosso Abelman, MD retweeted
Becky Zon, MD (@beckyzon) profile picture
Becky Zon, MD@beckyzon24 Jan 2023
Really honored to be able to lead this important work! Huge thanks to my mentor @connors_md and collaborators @LaurenMerzMD, @JessieStuart316, @lindali_md, @RachelAbelman, @AnnWoolleyMD, Kara Fields, Jess Grandoni, Becky Baron, and Gyorgy Frendl! A true team effort 💪🏼
Anesthesia&Analgesia (@IARS_Journals) profile pictureAnesthesia&Analgesia
@IARS_Journals23 Jan 2023
Replying to @IARS_Journals @beckyzon @LaurenMerzMD @JessieStuart316 @lindali_md @BrighamWomens
🔹Findings: An increased subdistribution hazard of arterial line dysfunction requiring replacement due to thrombosis was detected in COVID-19 pts compared to non–COVID-19 sepsis/ARDS pts in primary analysis, but finding not robust to sensitivity analysis buff.ly/3QxG5as
Image from Anesthesia&Analgesia (@IARS_Journals)
2
12
3,464
Rachel Occhiogrosso Abelman, MD retweeted
MGBCI Breast Oncology (@MGBCI_BreastOnc) profile picture
MGBCI Breast Oncology@MGBCI_BreastOnc2 Feb 2023
Check out this case report describing TRK inhibitor use in a patient with metastatic triple negative breast cancer and NTRK fusion that was just published in @TAMedOncol! #bcsm #oncoalert journals.sagepub.com/doi/10.…
Image from MGBCI Breast Oncology (@MGBCI_BreastOnc)
7
15
2,093
So excited to share our recent publication on antibody-drug conjugates! Thank you @dradityabardia @MGHBreastOnc and Hematology/Oncology clinics editor @DrHBurstein for this opportunity.
MGBCI Breast Oncology (@MGBCI_BreastOnc) profile pictureMGBCI Breast Oncology@MGBCI_BreastOnc21 Dec 2022
Excited about this publication of ADCs in clinical development for metastatic breast cancer, including implications for ADC sequencing, led by @RachelAbelman @jenny_keenan19 @dradityabardia! In @ElsevierConnect Hem/Onc Clinics, Lead Editor @DrHBurstein: sciencedirect.com/science/ar…
Image from MGBCI Breast Oncology (@MGBCI_BreastOnc)
2
9
1,594
This is so very cool. @OncoAlert
This Post is from an account that no longer exists. Learn more
3
10
Load more